ALBIREO PHARMA, INC. (ALBO) is a publicly traded company in the Unknown sector. Across all available filings, 20 corporate insiders have executed 208 transactions totaling $64.9M, demonstrating a bearish sentiment with -$3.9M in net insider flow. The most recent transaction on Mar 2, 2023 involved a transaction of 35,524 shares valued at $0.
No significant insider buying has been recorded for ALBO in the recent period.
No significant insider selling has been recorded for ALBO in the recent period.
Based on recent SEC filings, insider sentiment for ALBO is bearish with an Insider Alignment Score of 47/100 and a net flow of -$3.9M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at ALBIREO PHARMA, INC. (ALBO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 20 insiders are actively trading ALBO stock, having executed 208 transactions in the past 90 days. The most active insider is Advisors Llc Perceptive (Executive), who has made 8 transactions totaling $25.5M.
Get notified when executives and directors at ALBO file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Mar 2, 2023 | Mattsson Jan | Executive | Tender | 35,524 | $N/A | $0 | |
| Mar 2, 2023 | Duncan Jason | Executive | Tender | 3,296 | $N/A | $0 | |
| Mar 2, 2023 | J. Carter Martha | Executive | Tender | 3,656 | $N/A | $0 | |
| Mar 2, 2023 | Graham Michelle | Executive | Tender | 5,543 | $N/A | $0 | |
| Mar 2, 2023 | Stephenson Pamela | Executive | Tender | 22,242 | $N/A | $0 | |
| Mar 2, 2023 | Harold Wilfred Cooper Ronald | Executive | Tender | 33,094 | $N/A | $0 | |
| Mar 2, 2023 | N.r. Harford Simon | Executive | Tender | 13,739 | $N/A | $0 | |
| Mar 2, 2023 | Chiswell David | Executive | Tender | 56,278 | $N/A | $0 | |
| Jan 23, 2023 | J. Carter Martha | Executive | Sale | 120 | $43.80 | $5.3K | |
| Jan 23, 2023 | Harold Wilfred Cooper Ronald | Executive | Sale | 1,057 | $43.80 | $46.3K | |
| Jan 23, 2023 | Duncan Jason | Executive | Sale | 228 | $43.80 | $10.0K | |
| Jan 23, 2023 | N.r. Harford Simon | Executive | Sale | 102 | $43.80 | $4.5K | |
| Jan 23, 2023 | Mattsson Jan | Executive | Sale | 197 | $43.80 | $8.6K | |
| Jan 23, 2023 | Graham Michelle | Executive | Sale | 102 | $43.80 | $4.5K | |
| Jan 23, 2023 | Stephenson Pamela | Executive | Sale | 102 | $43.80 | $4.5K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 134 | $34.4M | 51.4% |
Purchase(P) | 6 | $30.5M | 45.6% |
Exercise(M) | 18 | $1.8M | 2.7% |
Payment(F) | 1 | $229.8K | 0.3% |
Tender(U) | 8 | $0 | 0.0% |
Award(A) | 41 | $0 | 0.0% |
Insider activity at ALBIREO PHARMA, INC. shows mixed signals across all time. While $30.5M in purchases indicates some executive confidence,$34.4M in sales balances the picture, resulting in a modest net flow of -$3.9M.20 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Advisors Llc Perceptive, has transacted $25.5M during this period.